Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator

被引：0
|
作者：
Magdolen, V [1 ]
de Prada, NA [1 ]
Sperl, S [1 ]
Muehlenweg, B [1 ]
Luther, T [1 ]
Wilhelm, OG [1 ]
Magdolen, U [1 ]
Graeff, H [1 ]
Reuning, U [1 ]
Schmitt, M [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Frauenklin, Klin Forschergrp, D-81675 Munich, Germany
来源：
CELLULAR PEPTIDASES IN IMMUNE FUNCTIONS AND DISEASES 2 | 2000年 / 477卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：331 / 341
页数：11
相关论文
共 50 条
  • [21] The Role of the Urokinase-Type Plasminogen Activator System In Tumor Progression
    E. V. Kugaevskaya
    T. A. Gureeva
    O. S. Timoshenko
    N. I. Solovyeva
    [J]. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2019, 13 : 97 - 112
  • [22] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    [J]. ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [23] Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase ε/PRSS22
    Yasuda, S
    Morokawa, N
    Wong, GW
    Rossi, A
    Madhusudhan, MS
    Sali, A
    Askew, YS
    Adachi, R
    Silverman, GA
    Krilis, SA
    Stevens, RL
    [J]. BLOOD, 2005, 105 (10) : 3893 - 3901
  • [24] Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator
    Yang, SQ
    Craik, CS
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1998, 279 (04) : 1001 - 1011
  • [25] Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
    Heynekamp, Justin J.
    Hunsaker, Lucy A.
    Deck, Lorraine M.
    Jagt, David L. Vander
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2553 - U2554
  • [26] Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator
    Swiercz, R
    Skrzypczak-Jankun, E
    Merrell, MM
    Selman, SH
    Jankun, J
    [J]. ONCOLOGY REPORTS, 1999, 6 (03) : 523 - 526
  • [27] Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor, and plasminogen activator inhibitor-1 and-2 in hepatocellular carcinoma
    Zhou, L
    Hayashi, Y
    Itoh, T
    Wang, WP
    Rui, JA
    Itoh, H
    [J]. PATHOLOGY INTERNATIONAL, 2000, 50 (05) : 392 - 397
  • [28] Plasma clearance of urokinase-type plasminogen activator
    van der Kaaden, ME
    Rijken, DC
    van Berkel, TJC
    Kuiper, J
    [J]. FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 (04): : 251 - 258
  • [29] Nuclear translocation of urokinase-type plasminogen activator
    Stepanova, V.
    Kuo, A.
    Higazi, A.
    Yarovoi, S.
    Bdeir, K.
    Cines, D.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 : 228 - 228
  • [30] Urokinase-type plasminogen activator, an endogenous antibiotic
    Jin, T
    Bokarewa, M
    Tarkowski, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (03): : 429 - 437
12345